The rising prevalence in GLP-1 agonists for metabolic health has led to a debate about formats: skin-applied devices versus capsules. Traditionally , GLP-1 therapies were only available in oral form, https://safiyagpfy057651.wssblogs.com/40865940/glp-1-skin-applications-vs-pills-what-suitable-for-individuals